Search - tctmd.com

Displaying 1 - 20 of 256

Sort: Relevancy | Date

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

November 04, 2025

Getting Ready for a Heart Failure Polypill, Well Before the Data Are In

News Daily News

Getting Ready for a Heart Failure Polypill, Well Before the Data Are In

October 16, 2025

After Acute HF Admission, Specialist Care Tied to Better Long-term Outcomes

News Daily News

After Acute HF Admission, Specialist Care Tied to Better Long-term Outcomes

October 07, 2025

HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease

News Daily News

HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease

October 02, 2025

Risk Factors Present in Nearly All Patients Who Develop CVD

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

Recognize and Enable Care for Post-MI Psychological Distress: AHA

News Daily News

Recognize and Enable Care for Post-MI Psychological Distress: AHA

October 01, 2025

CVD Still the Leading Cause of Death and Disease Globally

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

European Experts Provide Advice on Managing CV Effects of COVID-19

News Daily News

European Experts Provide Advice on Managing CV Effects of COVID-19

September 19, 2025

Transthyretin Cardiac Amyloidosis a Common Cause of HF in Older Black Patients

News Daily News

Transthyretin Cardiac Amyloidosis a Common Cause of HF in Older Black Patients

September 12, 2025

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

News Daily News

Prevention Must Be Prioritized in Heart Failure Care: HFSA/ASPC

Yael L. Maxwell

August 18, 2025

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

HF Risks Stick Around Even When Ejection Fraction Improves

News Daily News

HF Risks Stick Around Even When Ejection Fraction Improves

August 01, 2025

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

July 24, 2025

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

News Daily News

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

July 24, 2025

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

News Daily News

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

July 14, 2025

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

No Change in HF Outcomes When Private Equity Buys the Hospital

News Daily News

Private Equity-Backed Hospitals Appear to 'Cherry-Pick' HF Patients

Michael O'Riordan

June 16, 2025

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

News Daily News

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

June 05, 2025

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

News Daily News

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

May 09, 2025

STRONG-HF Analysis Quantifies Gains From Rapid Uptake of GDMT

News Daily News

STRONG-HF Analysis Quantifies Gains From Rapid Uptake of GDMT

May 08, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.